chrisvoncsefalvay/vaers-outcomes huggingface dataset:
left index finger hurting and swollen under side of index finger hurts to move finger; left index finger hurting and swollen under side of index finger hurts to move finger; Side to side fast vision is floaties for about hour/Grey boxes floating sideways; white tear drops floating left side down to up; ears ringing; sometimes when I am outside the color is dimmer like a filter is put over my eye; headache after the side to side; have in spots like a magnifying effect top left and lower right side lately; when I blink I have a Vaseline effect but goes away; depth perception is off more than usual, vision blurry up close when close up was clearer to read that's with glasses; depth perception is off more than usual, vision blurry up close when close up was clearer to read that's with glasses; This is a spontaneous report from a contactable consumer (patient).  This 56-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number unknown), via an unspecified route administered in the left arm, on 09Jun2021 11:00 (at the age of 56-year-old) at single dose (dose number unknown) for COVID-19 immunisation, administered at Pharmacy/Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Relevant medical history included Hepatitis C, coconut allergy, 'daladas' (as reported) allergy, and lactose intolerance. The patient was in menopause. The patient did not have COVID-19 before vaccination. Past drug history included sulfanilamide (SULFA) allergy. The patient did not have concomitant medications. The patient verbally reported as follows: on 11Jun2021, side to side fast vision is floaties for about hour, grey boxes floating sideways, white tear drops floating left side down to up, ears ringing, sometimes when I am outside the color is dimmer like a filter is put over my eye, headache after the side to side but ibuprofen and darkness help, sometimes I have in spots like a magnifying effect top left and lower right side lately, if I wear my sunglasses when outside eye doesn't bother me when I could be without. Sometimes when I blink I have a Vaseline effect but goes away, depth perception is off more than usual, vision blurry up close when close up was clearer to read that's with glasses. On 20Sep2021, the patient woke up with left index finger hurting and swollen under side of index finger hurts to move finger. No seriousness criterion was provided. The patient was treated for 'headache', 'sometimes when I am outside the color is dimmer like a filter is put over my eye' and 'have in spots like a magnifying effect top left and lower right side lately'. No treatments were given for the remaining events. Post vaccination COVID-19 test was not done. The patient had not recovered from the events.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Had an audit on 6/26/23 and was found during the audit that this pt was given a 1st dose of the 5-11 pfizer vaccine orange cap on 12/08/2021, no reaction to the first dose, pt then came in on 12/31/2021 for the 2nd dose, however was documented as being given a gray top 12 year old dose, unsure if this was the lot that was given at the time, however this is what is documented. pt did not come back with any side effects. Spoke to Pfizer on 6/28/23 and was advised that pt no longer needs another vaccine since they have received that higher dose that day. Was not aware of any effects from this pt after the vaccine was given in 2021
affected her rheumatoid arthritis she had a flare up- bad time with hip,ankle and a pain that went across her shoulder; A spontaneous report was received from a consumer concerning 74-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and it affected her rheumatoid arthritis she had a flare up/ rheumatoid arthritis, bad time with hip, ankle a pain that went across her shoulder/ arthralgia.  The patient's medical history was not reported by the reporter. Concomitant medications taken by the patient were not provided.  On 15 Feb 2021, prior to the onset of the event, the patient received first of their two planned doses of mRNA-1273 (Lot number: 029L2OA) through unknown route at unspecified site for prophylaxis of COVID-19 infection.  On 16 Mar 2021, prior to the onset of the event, the patient received second of their two planned doses of mRNA-1273 (Lot number: 001B21A) through unknown route at unspecified site for prophylaxis of COVID-19 infection.  On 15 Feb 2021, after vaccination it affected her rheumatoid arthritis and she had a flare up, she had a bad time with hip, ankle a pain that went across her shoulder. Since then her healthcare professional had recommended, her to go to physical therapy.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of event, it affected her rheumatoid arthritis she had a flare up was not recovered. Outcome of the event of she had a bad time with hip, ankle a pain that went across her shoulder was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-048050:crosslink for second dose events
Vision blurred sort of as if I had just been staring into a bright light. I was unable to read words on my computer screen when I got back to work.
No reaction noted. Accidentally administered KINRIX when DTaP was required. DTaP was meant to be given.
This report describes the occurrence of autism spectrum disorder in a male child of unspecified age who was vaccinated with Infanrix and hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of Infanrix on 11/14/97 (lot 4027A; not a valid lot number) and 1/15/98 (lot 839A2). He received injections of Engerix B on 9/26/97 (lot 405A2) and 11/14/97 (lot 2405A2).. The subject' attorney stated, "We believe that as a result of (the subject's) exposure to thimerosal from the above vaccine (sic), he sustained neurological injuries and as a result of those injuries has been diagnosed with autism spectrum disorder." Time to onset, treatment, and outcome of the event were not provided. The autism spectrum disorder in this report is considered medically serious (OMIC).
COVID+ 6/14, symptom start 6/11 - body aches, headache, nasal congestion, loss of smell. Presumed COVID exposure 6/6
Information has been received from a registered nurse via a company representative concerning a 16 year old female who, "the other night", was vaccinated with a first dose of HPV vaccine (yeast) (lot# not reported). The nurse reported that girl passed out in the office and hit her head after receiving a first dose of vaccine.  The girl was unconscious in the office waiting room 3 to 4 minutes.  It was reported that the patient was "revived" by using ammonia inhalant, and "seemed to take longer than expected to regain consciousness." The patient was administered an office neurological exam which was "ok and the patient was sent home", reported as recovered.  The nurse also reported that it was unclear if this injection was painful.  Additional information has been requested.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2022 at 6:18 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 25-Jan-2022 at 6:18 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant medication was reported by reporter.  Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021. Booster dose was given on 25-Jan-2022 18:18:18.  No treatment medication was reported by reporter.
Insomnia.  Have not been able to fall asleep even when completely exhausted.  Awake feeling.  Have had to take sleeping medication to fall asleep and even then I am restless for a good while.
Pt states on 3DEC91 pt awoke w/shoulder & back pain no tx sought; 5DEC rt knee swelled & became painful then better the next day sl but worsened again; pt called MD & saw MD 10DEC91 & 23DEC91 had numerous test dx w/infl arthritis;
PT RETURNED TO CLINIC WITH SWELLING, REDNESS, AND HEAT TO SITE OF INJECTION.  SIZE OF SWELLING AND INDURATION 30X40MM.  PT RECEIVED VACCINE 11/22/04 AND REPORTED ADVERSE REATION 11/22/04.
1604  rt deltoid swelling raised area 2 in. in diameter no rendess/drainage ice pack applied new band aid applied 1620  swelling reduced pt left after visualizing and verbalizing no additional change or concern
When we checked on patient in about 5 minutes after shot, patient complained about tightness is his neck and felt a lump in his throat. I did give me 25mg of liquid generic benadryl.  Monitored with a epi pen, bought never gave it to him because I didn't feel he was in breathing distress. He did want us to call the ambulance and they came in and determined he was not having a allergic reaction.
ACHY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) .5 ml, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-MAR-2021, the subject experienced achy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achy on 11-MAR-2021. This report was non-serious.
caught covid; caught covid; had a bad fall; colitio; migraines / awful migraines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Migraine" (unspecified if ongoing), notes: had not have one in twenty years. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "caught covid"; FALL (medically significant), outcome "unknown", described as "had a bad fall"; COLITIS (medically significant), outcome "unknown", described as "colitio"; MIGRAINE (non-serious), outcome "unknown", described as "migraines / awful migraines". The event "colitio" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of colitis. Detail course was reported as the patient had on shot of Pfizer vaccine, did not have 2nd shot. The patient caught covid and had a bad fall and colitio, had emergency surgery. The patient had covid 3 times. The patient used to get migraines and had not have one in twenty years, after the 2nd and 3rd covid outbreak patient had awful migraines.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Client stated she felt a warm sensation going down her left arm.  "almost like a hot flash, but just in my arm".  Client continued to be coherent. 4:20 pm  B/P 122/90/98   pulse=78   Pulse Oximeter 98% 4:25 pm  B/P 122/88   pulse=79   Pulse Oximeter 98% 4:30 pm  B/P 128/88   pulse=80   Pulse Oximeter 99% Client stated she felt fine.  Released from clinic site.  Encouraged to contact medical provider if symptoms returned.
Hospitalized with AFIB; A spontaneous report was received from a consumer concerning a  female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the following: hospitalized with AFIB (atrial fibrillation).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Hospitalized with AFIB.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event(s), hospitalized with afib was unknown.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
12 minutes after receiving the 2nd covid vaccination, I felt flushed and became diaphoretic. I felt heart palpitations and checked my heart rate which was 117, increasing to a max of 123.  I was placed on a pulse ox monitor, which showed 93%, BP was elevated at 146/85. I was not given any  medical treatment, and was placed on a monitor for one hour.  Once my hr and 02 stas were at my baseline, I was allowed to be discharged. I went back to my department and  decided to go home, as I felt tired and was mildly nauseous.
Information has been received from a physician concerning a 60 year old female who, "in last week", on approximately 24-Nov-2008 was vaccinated with a dose of ZOSTAVAX. Subsequently the patient experienced blisters, fever and aching. The patient was not taking any new medications and she was otherwise healthy. At the time of this report, 03-Dec-2008, the outcome was unknown. Follow-up information was received from a physician. The physician did not remember the details of the reaction. Further information was not available.
Dizziness 1-4 times daily, tinnitus-pulsating, chills
Headache, low-grade fever (99.2), fatigue, loss of appetite, sore arm. Sore arm lasted for 3 days, but the other symptoms only lasted about 12 hours.
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used).    No concomitant medications details were reported.  Patient received vaccine at Pharmacy.  Beyond use date of the vaccine was 17-Feb-2022.  No treatment medications details were reported.  NDC number was reported as 80777-273-10.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added. Case narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
Bilateral, high-pitched tinnitus beginning approx 2 weeks after flu vaccine. Has now had symptoms for 10 days. Otherwise well and no other identified etiology.
I had a bad headache, sore throat, runny nose. I was beginning to get a cough but I got the Paxlovid in time to shortcut that.
Fever of 103.7 F with lethargy the eve of vaccinations and fever with lethargy 104.0 F post vaccination day 1.
SM developed a pericarditis with cyclic fevers and exercise intolerance treated with rest and NSAIDs. 14 day cardiac monitoring has been unremarkable as has stress test and echo. Cardiac MRI is pending. Symptoms began about 2 days after vaccination and improved after 6 weeks and by 3 months have nearly completely resolved.
Red and warm lesion  in the arm around the shot. Little bit itchy and sometimes painful when touched.
possible chest pain; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date in 2021 (Batch/Lot number was not reported) as UNKNOWN DOSE, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced possible chest pain on an unspecified date in 2021. The patient reported having gotten what was believed to have been reported as the Pfizer shot on Saturday and was at the ER (Emergency Room). Patient possibly reported chest pain, but unable to clarify if that was captured correctly as patient declined to clarify information provided on call, she had to go, was in the ER, and disconnected the call. The outcome of the event was unknown.  Follow-up attempts have been completed and no further information is expected.
Blurry vision; Double vision; This is a spontaneous report from a contactable consumer, the patient. A 47-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 30Mar2021 at 14:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19. Concomitant medication included rosuvastatin (MANUFACTURER UNKNOWN) from unknown date from unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 09Mar2021 at 14:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 30Mar2021 at 1700, after second dose, the patient experienced blurry vision and double vision which lasted for around five hours. The patient did not receive any treatment for the adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of blurry vision and double vision were resolved on 30Mar2021 at 22:00.   No follow-up attempts are needed. No further information is expected.
SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 36 year male of an unspecified race. The patient's height, and weight were not reported. The patient's past medical history included: right hip replacement, and concurrent conditions included: drug allergy (not reported), and other pre-existing medical conditions included: Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: UNKNOWN) dose was not reported, 1 total administered on an unspecified date in left arm for covid-19 prophylaxis. It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1) . The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, 1 total administered on 08-DEC-2021 08:00 in left arm for covid-19 prophylaxis. Age at time of vaccination 35 years old. No concomitant medications were reported.  On 27-DEC-2022 14:00, the patient had metallic taste that had lead to nausea and had covid-19 infection (suspected covid-19 infection, dose number in series 2) for which patient received treatment of Paxlovid (form of admin and route of admin were not reported, batch number: GF 4083, expiry: UNKNOWN) dose was not reported, administered on 27-DEC-2022 for treatment of covid-19. Date of last administration was 28-DEC-2022. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 infection was not reported. This report was non-serious.
JOINT PAIN; FATIGUE; FEVER; MILD HEADACHE; This spontaneous report received from a patient concerned a 51 year old. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 to left deltoid for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the patient experienced mild headache. On 06-APR-2021, the patient experienced joint pain. On 06-APR-2021, the patient experienced fatigue. On 06-APR-2021, the patient experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, joint pain, fever, and mild headache. This report was non-serious.
Lightheadedness and rapid more shallow breathing 10 minutes after injection. Lasted about 10 minutes, began to subside and were gone in about 30 more minutes.
Extreme weakness, diarrhea, unresponsive, BP 66/34. (during the night following the vaccine. Next couple days tired and weak).
Sore Right Arm and swollen vein ; ultrasound confirmed a blood clot in Right Arm.  Trip to ER 6/30/21; put on blood thinner.  No history of blood clots.. self or family. 2nd vaccine shot was 6/22/21   LOT EW0217
Redness and swelling at the left thigh. coughing x 1 day, Dtap.